What are the side effects of Mounjaro — and how do most people find them?

GI effects are the most common: nausea, diarrhoea, vomiting and constipation affect a significant proportion of users, most often early in treatment and after each dose step up.
Most side effects are temporary: for the majority of people, gut symptoms ease within days to a couple of weeks as the body adjusts — they rarely stay at the same intensity throughout treatment.
Serious side effects exist but are uncommon: pancreatitis, gallbladder problems and severe allergic reactions require prompt medical attention; the MHRA issued a specific Drug Safety Update on acute pancreatitis for GLP-1 medicines in January 2026.
Yellow Card reporting matters: if you experience a suspected side effect on Mounjaro, you can report it directly to the MHRA at yellowcard.mhra.gov.uk, your report contributes to ongoing safety monitoring of this medicine.

The most commonly reported side effects of Mounjaro (tirzepatide) are gastrointestinal: nausea, diarrhoea, vomiting, constipation and indigestion appear most often, particularly in the first weeks of treatment or after a dose increase. These effects are well-documented in clinical trial data and in the NHS's own medicine guidance, and for most people they are temporary. Mounjaro is a prescription-only medicine, so a prescriber assesses whether it is suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding Mounjaro's side-effect profile: from trial evidence to everyday experience

What the clinical trial data actually showed about side effects

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed over 2,500 adults taking tirzepatide across 72 weeks. Gastrointestinal events were consistently the most reported adverse effects at every dose level tested. Nausea was the most frequent, followed by diarrhoea, vomiting, constipation, indigestion and burping. Crucially, the trial also showed that the majority of these events were mild to moderate in severity, and that they clustered around the start of treatment and around each dose increase rather than persisting continuously.

The NHS medicines page for tirzepatide confirms this profile and notes that fatigue, headache, dizziness and injection-site reactions (redness, bruising or mild discomfort where the pen is used) are also among the more commonly observed effects. Injection-site symptoms tend to settle quickly, especially with good rotation across the abdomen, thigh and upper arm.

One practical detail worth knowing: Mounjaro slows how quickly the stomach empties food. This is part of why it reduces appetite, but it also explains the nausea pattern. If you want a thorough breakdown of Mounjaro side effects, including how common each one is and what typically triggers them, our dedicated page covers the full picture. Eating smaller portions, avoiding high-fat meals and staying well-hydrated can all help the body tolerate the medicine more comfortably, especially in the early weeks. Your prescriber will discuss this with you.

Side effects that need prompt medical attention

A small number of side effects require urgent assessment rather than watchful waiting. The clearest signal is severe, persistent stomach pain that radiates to the back, with or without vomiting, this pattern can indicate acute pancreatitis, and you should seek medical help straight away rather than waiting to see whether it passes. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent risk of GLP-1 receptor agonist medicines, including tirzepatide, and reinforcing the importance of recognising this symptom early.

Other situations that warrant prompt attention include: symptoms that suggest a gallbladder problem such as upper-right abdominal pain, fever or jaundice; signs of significant dehydration from prolonged vomiting or diarrhoea, including reduced urination or dizziness on standing; signs of a serious allergic reaction such as swelling of the face or throat, difficulty breathing or a widespread rash; and any new or worsening feelings of low mood or thoughts of self-harm. These are uncommon, but they are not trivial. Our page on what are the side effects of taking Mounjaro goes into further detail on which symptoms to monitor closely and when to act.

If you are being treated through our pharmacy and something concerns you, the team is available seven days a week, details are on the contact page. For anything urgent, NHS 111 or your GP remains the right first call.

Who is more likely to notice side effects, and when do they peak?

The evidence consistently points to the early weeks of treatment (and the period around each dose increase) as the most likely time for gut symptoms. The titration schedule exists partly for this reason: starting at a low dose and stepping up gradually gives the body time to adjust before the next increase. People who start at a lower body weight relative to the dose, those with a history of reflux or sensitive digestion, and those who do not reduce portion sizes during treatment appear more likely to report pronounced nausea. Our page explaining what's the side effects of Mounjaro includes guidance on which groups tend to find the early weeks harder and why.

Side effects that persist beyond two or three weeks without any settling, or that are severe enough to affect daily life, are worth raising with a prescriber rather than pushing through. A dose pause or a slower titration can often make a significant difference. Our FAQs page covers some of the most common questions about managing the early weeks, and our clinical team (led by our clinical director) reviews every patient's progress as part of repeat orders.

For a fuller picture of how Mounjaro works and what to expect throughout treatment, the Mounjaro overview page covers the mechanism, the evidence on results and the access process in one place.

Reporting side effects and what happens next

The MHRA's Yellow Card scheme is the UK's system for collecting reports of suspected side effects from medicines and medical devices. Reporting is open to patients as well as healthcare professionals, and it plays a real role in how the regulator monitors medicines once they are in widespread use, tirzepatide carries a Black Triangle (▼) status, meaning it is under additional MHRA surveillance while longer-term real-world data accumulates. Patients often ask us what are the long term side effects of Mounjaro, and our page on that topic explains what the surveillance data gathered so far does and does not yet tell us.

You can submit a report at any time at yellowcard.mhra.gov.uk. You do not need to be certain the medicine caused the effect, a suspicion is enough to make a report worthwhile. The same site allows you to flag any concerns about the authenticity of medicine you have received, which matters given the MHRA's warnings about counterfeit weight-loss pens circulating outside the licensed supply chain.

When a Mounjaro pen arrives from our pharmacy, it comes in plain, unbranded packaging via DPD with a tracking notification sent to your phone, so you know exactly when to expect it and can be sure it has travelled through the cold chain correctly. The pen itself carries the Eli Lilly labelling, batch number and expiry date you would expect from a licensed UK product. If anything looks wrong, contact us before using it.

People considering treatment can explore what is involved through the weight-loss treatments page, where our prescribers discuss suitability and side effects as part of the free consultation, there is no obligation to proceed. You may also find it useful to read through our page on what are the side effects of Mounjaro before your consultation, so you can go in with informed questions ready.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions